While much of the focus of anti-cancer therapies has been on oncogenic signaling networks, including hormone receptors and kinases, cancer cells show incredible plasticity in rewiring their metabolic preferences according to the available nutrients in order to enhance survival. This evidence concerns the gene NR4A1 and cancer.